| Date Filed | Type | Description |
| 07/05/2023 |
4
| ALTMAN MICHAEL SETH (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $4.11, valued at
$82.2k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| ALTMAN MICHAEL SETH (CFO) has filed a Form 4 on ARYA Sciences Acquisition Corp V|
Txns:
| Granted 499,000 shares
@ $10, valued at
$5M
|
|
| 07/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| ALTMAN MICHAEL SETH (CFO) has filed a Form 4 on ARYA Sciences Acquisition Corp IV|
Txns:
| Granted 499,000 shares
@ $10, valued at
$5M
|
|
| 02/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2020 |
4
| ALTMAN MICHAEL SETH (CFO) has filed a Form 4 on ARYA Sciences Acquisition Corp II|
Txns:
| Acquired 499,000 shares
@ $10, valued at
$5M
|
|
| 06/04/2020 |
3
| ALTMAN MICHAEL SETH (CFO) has filed a Form 3 on ARYA Sciences Acquisition Corp II |
| 05/01/2020 |
4
| ALTMAN MICHAEL SETH (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 14,500 options
@ $16, valued at
$232k
|
|
| 04/30/2020 |
3
| ALTMAN MICHAEL SETH (Director) has filed a Form 3 on Lyra Therapeutics, Inc. |
| 10/05/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |